Abstract:Acute inflammatory exacerbations (AIEs) represent immune-driven deteriorations of many chronic lung conditions, including COPD, asthma, and pulmonary fibrosis (PF). The first line of therapy is represented by broad-spectrum immunomodulation. Among the several inflammatory populations mobilizing during AIEs, eosinophils have been identified as promising indicators of an active inflammatory exacerbation. To better study the eosinophil-parenchymal crosstalk during AIE-PF, this work leverages a clinically relevant model of inflammatory exacerbations triggered by inducible expression of a mutation in the alveolar epithelial type 2 cell Surfactant Protein-C gene [SP-C I73T ]. Unbiased single-cell sequencing analysis of controls and SP-C I73T mutants at a time coordinated with peak eosinophilia (14 days) defined heightened inflammatory activation, chemotaxis, and survival signaling (IL-6, IL-4/13, STAT3, Glucocorticoid Receptor, mTOR, and MYC) in eosinophils. To study the impact of eosinophils in inflammatory exacerbations, the SP-C I73T line was crossed with eosinophil lineage deficient mice (GATA1 Δdbl ) to produce the SP-C I73T GATA1 KO line. Time course analysis (7–42 days) demonstrated improved lung histology, survival, and reduced inflammation in SP-C I73T GATA1 KO cohorts. Spectral flow cytometry of tissue digests confirmed eosinophil depletion in GATA1 KO mice and the absence of a compensatory shift in neutrophils and immature monocyte recruitment. Eosinophil deletion resulted in progressive monocyte-derived macrophage accumulation (14 days post-injury), combined with declines in CD3 + CD4 + lymphocyte and B220 + B cell abundance. Histochemical analysis revealed atypical inflammatory cell activation in SP-C I73T GATA1 KO mice, with reduced numbers of Arg-1 + and iNOS + cells, but increases in tgfb1 mRNA expression in bronchoalveolar lavage cells and tissue. Dexamethasone treatment (1 mg/kg daily, i.p.) was utilized to investigate corticosteroid efficacy in highly eosinophilic exacerbations induced by mutant SP-C I73T . Dexamethasone successfully reduced total and eosinophil (CD11b + SigF + CD11c − ) counts at 14 days and was linked to reduced evidence of structural damage and perivascular infiltrate. Together, these results illustrate the deleterious role of eosinophils in inflammatory events preceding lung fibrosis and demonstrate the efficacy of corticosteroid treatment in highly eosinophilic exacerbations induced by mutant SP-C I73T .

PDGFR{alpha}-positive fibroblasts display a proinflammatory phenotype in infection-driven exacerbation of experimental lung fibrosis

Spatial and phenotypic heterogeneity of resident and monocyte-derived macrophages during inflammatory exacerbations leading to pulmonary fibrosis

Angiotensin-converting Enzyme Defines Matrikine-Regulated Inflammation and Fibrosis

Pneumocystis carinii infection drives upregulation of Fn1 expression that causes pulmonary fibrosis with an inflammatory response

Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung

Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.

TGF-β, Smad3 and the process of progressive fibrosis

CD103+ Dendritic Cell - Fibroblast Crosstalk via TLR9 and AHR Signaling Drives Lung Fibrogenesis

Identification of Ephrin type-B receptor 4 as a critical mediator of tissue fibrosis

Disruption of Prostaglandin F2 α Receptor Signaling Attenuates Fibrotic Remodeling and Alters Fibroblast Population Dynamics in A Preclinical Murine Model of Idiopathic Pulmonary Fibrosis

TGF{beta} drives fibrotic remodeling via modulation of homeostatic and pathological fibroblast populations in a murine model of pulmonary fibrosis

Immunophenotyping of Acute Inflammatory Exacerbations of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils

CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity

Dysregulated Cell–Cell Communication Characterizes Pulmonary Fibrosis

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives

Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis

The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis

FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis

Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts

Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis

The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis